APOTHEEK DE MAN
ActiveAPOTHEEK DE MAN has been active since 1990 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €86k and a net result of €143k. Equity remains stable across the filed fiscal years (±0.5% per year). Its solvency ranks better than 19% of 4147 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).
Checked score
Score 2025
67
/ 100
Healthy
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability86▲+4
Solvency33=
Growth52=
Track record100
Bankruptcy probability, 12 months
0.4%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €5k at 30 days acceptable
Liquidity tight (current ratio 1.37 against 1.48 in 2024; short-term debt: 50.3% and cash: 20.7% of total assets), and 91.9% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Eight signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
8.1%
Return on assets
13.5%
Age of the figures
9 mo
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 19% of 4147 sector peers (2025).
NBB · sector comparisonPosition among 4147 sector peers
Solvency
better than 19%
← weakest
strongest →
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 26-08-2026, 26 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
26 d late
2024
14 d late
2023
22 d late
2022
30 d late
2021
16 d early
2020
60 d early
2019
21 d early
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
20-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, full schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€143k▲ 36.1%
2024 · €105k
2018: €157k
2019: €172k
2020: €181k
2021: €199k
2022: €169k
2023: €69k
2024: €105k
2018 → 2025
Working capital
€199k▼ 7.4%
2024 · €215k
2018: €-291k
2019: €-291k
2020: €-299k
2021: €-292k
2022: €-267k
2023: €185k
2024: €215k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€84k-€85k▲ 0.5%€86k▲ 1.6%€86k=€86k=
Operating result€200k-€182k▼ 9.0%€77k▼ 57.5%€153k▲ 97.7%€197k▲ 29.1%
Net result€199k-€169k▼ 15.0%€69k▼ 59.4%€105k▲ 53.4%€143k▲ 36.1%
Result per fiscal year
Operating resultNet result
After the dip in 2023 the operating result has climbed two years in a row; 2025 is 29% above 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.06M
Fixed assets
€329k▼ 6.2%
Current assets
€733k▲ 9.7%
Equity and liabilities €1.06M
Equity
€86k=
Debt
€975k▲ 4.6%
The debt ratio rises from 91.5% to 91.9%. Debt is higher.
Key figures and ratios
EBITDA
€223k▲
2024 · €178k
Cash flow
€169k▲
2024 · €130k
Solvency
8.1%▼
2024 · 8.5%
Current ratio
1.37▼
2024 · 1.48
Quick ratio
0.88▼
2024 · 1.02
Debt / equity
11.32▲
2024 · 10.83
ROE
166.4%▲
2024 · 122.3%
ROA
13.5%▲
2024 · 10.3%
Interest coverage
12.23▲
2024 · 9.06
Debt
€975k▲
2024 · €933k
Debt ≤ 1 year
€534k▲
2024 · €453k
Debt > 1 year
€366k▼
2024 · €400k
Income taxes
€38k▲
2024 · €30k
Staff costs
€156k▼
2024 · €197k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€1.02M€1.06M▲
Fixed assets21/28€351k€329k▼
Tangible fixed assets22/27€345k€320k▼
Land and buildings22€303k€289k▼
Plant, machinery and equipment23€38k€29k▼
Furniture and vehicles24€4k€2k▼
Financial fixed assets28€5k€9k▲
Current assets29/58€668k€733k▲
Stocks and contracts in progress3€206k€262k▲
Stocks30/36€206k€262k▲
Amounts receivable within one year40/41€151k€224k▲
Trade receivables40€144k€194k▲
Other amounts receivable41€7k€31k▲
Cash at bank and in hand54/58€289k€220k▼
Deferred charges and accrued income490/1€23k€27k▲
Equity and liabilities
Total equity and liabilities10/49€1.02M€1.06M▲
Equity10/15€86k€86k=
Contributions10/11€62k€62k=
Capital10€62k€62k=
Issued capital100€62k€62k=
Reserves13€24k€24k▲
Non-distributable reserves130/1€6k€6k=
Legal reserve130€6k€6k=
Distributable reserves133€18k€18k▲
Profit (loss) carried forward14€0€0=
Amounts payable17/49€933k€975k▲
Amounts payable after more than one year17€400k€366k▼
Financial debts170/4€400k€366k▼
Amounts payable within one year42/48€453k€534k▲
Current portion of amounts payable after more than one year42€33k€33k▲
Trade debts44€32k€36k▲
Suppliers440/4€32k€36k▲
Taxes, remuneration and social security45€34k€27k▼
Taxes450/3€0-
Remuneration and social security454/9€34k€27k▼
Other amounts payable47/48€353k€436k▲
Accrued charges and deferred income492/3€80k€76k▼
Income statement
Code20242025
Remuneration, social security and pensions62€197k€156k▼
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€25k€25k▲
Other operating charges640/8€5k€5k▲
Gross operating margin9900€380k€385k▲
Operating profit (loss)9901€153k€197k▲
Financial income75/76B€2k€2k▲
Recurring financial income75€2k€2k▲
Financial charges65/66B€20k€18k▼
Recurring financial charges65€20k€18k▼
Profit (loss) for the period before taxes9903€135k€181k▲
Income taxes67/77€30k€38k▲
Profit (loss) for the period9904€105k€143k▲
Profit (loss) for the period to be appropriated9905€105k€143k▲
Appropriation of the result
Profit (loss) to be appropriated9906€105k€143k▲
Transfer to equity691/2€28€17▼
To other reserves6921€28€17▼
Profit to be distributed694/7€105k€143k▲
Return on contributions (dividend)694€83k€105k▲
Directors or managers695€22k€38k▲
Social balance
Average headcount (FTE)90872.92.9=
The notes to these accounts (21 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
26-08
NBB filing
Annual accounts filed
fiscal year 2025 · full schema · 26 days late
2025
14-08
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema · 14 days late
2024
22-08
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema · 22 days late
2023
31-12
Financial
Weakest financial yearnet €69k ▼59.4%
Net result drops to €69k, the lowest in the series; recovery starts the following year.
31-12
Financial
Liquidity doublescurrent ratio 1.49
Current ratio from 0.72 to 1.49; short-term debt falls from €948k to €380k.
30-08
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema · 30 days late
2022
15-07
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
31-12
Financial
Highest result since 2018net €199k ▲10.2%
Operating result €200k, net result €199k, both a record.
01-06
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
10-07
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema
2019
04-07
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema
2018
18-06
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
14-06
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
5 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Sint-Truiden · 1 establishment unit since 1991
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Eynestraat 933800 Sint-TruidenGround area
1,827 m²
Building footprint
375 m²
Volume, LiDAR
2,024 m³
Parcel 71064A0686/00Y000, Flanders · tallest building 9.7 m, ±1 floor. Linked by address, not a title deed.
1 establishment unit
APOTHEEK DE MAN
since 19912.051.538.023
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 71064A0686/00Y000 | Flanders | 1,827 m² | 1 · 375 m² | 9.7 m · 1 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Food safety, FASFC
1 siteSint-Truiden2.051.538.023
Similar companies · same sector, comparable size
ANTOINE DERBAUD
BE 0786.472.040
Ham-sur-Heure-Nalinnes · Eq €86k
APOTHEEK VAN OVERBERGE - VAN DEN STEEN
BE 0457.932.941
Gent · Eq €86k
Farmajes
BE 0681.788.254
Antwerpen · Eq €86k
VANCOPHAR
BE 0540.905.553
Bierbeek · Eq €86k
APOTHEEK RUMMEN
BE 0790.436.667
Geetbets · Eq €86k
Of 5,222 companies in sector 47730 we hold annual accounts for 3,861. 3,313 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPublic limited company
Founded12-12-1990
Fiscal year end31-12
Activities, NACEBEL
47730Retail sale of pharmaceutical products
52310
Sources
Crossroads Bank for EnterprisesNational Bank · 35 filingsAddress and cadastre registers
Data from official sources, last processed on 20-09-2026. Scores and ratios are computed by Checked and are not a credit decision.